{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T20:17:31Z","timestamp":1780085851707,"version":"3.54.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T00:00:00Z","timestamp":1652054400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014716","name":"Hualien Tzu Chi Hospital Buddhist Tzu Chi Medical Foundation","doi-asserted-by":"publisher","award":["TCRD109-74"],"award-info":[{"award-number":["TCRD109-74"]}],"id":[{"id":"10.13039\/501100014716","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022298","name":"Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022298","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005925","name":"Buddhist Tzu Chi Medical Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.jmii.2022.04.011","type":"journal-article","created":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T13:57:06Z","timestamp":1652795826000},"page":"643-650","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Improvement of patient-reported outcomes in patients achieving sustained virologic response with direct-acting antivirals for hepatitis C virus infection"],"prefix":"10.1016","volume":"55","author":[{"given":"Chih-Hsun","family":"Yi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Jong","family":"Bair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4946-8064","authenticated-orcid":false,"given":"Jen-Hung","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Wun","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tso-Tsai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Yi","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8426-4422","authenticated-orcid":false,"given":"Shu-Wei","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7866-964X","authenticated-orcid":false,"given":"Jui-Sheng","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2752-7051","authenticated-orcid":false,"given":"Jee-Fu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-Chun","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9084-8210","authenticated-orcid":false,"given":"Chien-Lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmii.2022.04.011_bib1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJM200107053450107","article-title":"Hepatitis C virus infection","volume":"345","author":"Lauer","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmii.2022.04.011_bib2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jfma.2015.06.012","article-title":"Hepatitis C virus infection in Taiwan: past, present, and future","volume":"115","author":"Kao","year":"2016","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jmii.2022.04.011_bib3","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S2468-1253(16)30181-9","article-title":"Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study","volume":"2","author":"Polaris Observatory","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jmii.2022.04.011_bib4","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s12072-015-9629-x","article-title":"A review of the burden of hepatitis C virus infection in China, Japan, South Korea and Taiwan","volume":"9","author":"Bennett","year":"2015","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jmii.2022.04.011_bib5","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/j.jhep.2014.07.027","article-title":"Global epidemiology and genotype distribution of the hepatitis C virus infection","volume":"61","author":"Gower","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jmii.2022.04.011_bib6","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1053\/j.gastro.2016.02.039","article-title":"Extrahepatic manifestations of hepatitis C: a meta-analysis of prevalence, quality of life, and economic burden","volume":"150","author":"Younossi","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jmii.2022.04.011_bib7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/00005792-200001000-00005","article-title":"Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d\u2019Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l\u2019Hepatite C","volume":"79","author":"Cacoub","year":"2000","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jmii.2022.04.011_bib8","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.kjms.2017.07.003","article-title":"The outcomes of glucose abnormalities in chronic hepatitis C patients receiving interferon-free direct antiviral agents","volume":"33","author":"Huang","year":"2017","journal-title":"Kaohsiung J Med Sci"},{"key":"10.1016\/j.jmii.2022.04.011_bib9","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1111\/j.1572-0241.2007.01181.x","article-title":"Hepatitis C viremia increases the association with type 2 diabetes mellitus in a hepatitis B and C endemic area: an epidemiological link with virological implication","volume":"102","author":"Huang","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jmii.2022.04.011_bib10","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jhep.2016.09.001","article-title":"Electronic address eee. EASL recommendations on treatment of hepatitis C 2016","volume":"66","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.jmii.2022.04.011_bib11","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1007\/s12072-016-9717-6","article-title":"APASL consensus statements and recommendation on treatment of hepatitis C","volume":"10","author":"Omata","year":"2016","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jmii.2022.04.011_bib12","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/hep.27950","article-title":"Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus","volume":"62","author":"Panel","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jmii.2022.04.011_bib13","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1001\/jama.2012.144878","article-title":"Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis","volume":"308","author":"van der Meer","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jmii.2022.04.011_bib14","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/infdis\/jis385","article-title":"Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study","volume":"206","author":"Lee","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jmii.2022.04.011_bib15","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jhep.2016.10.017","article-title":"Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication","volume":"66","author":"van der Meer","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.jmii.2022.04.011_bib16","series-title":"Global health sector strategy on viral hepatitis 2016-2021. Towards ending viral hepatitis","year":"2016"},{"key":"10.1016\/j.jmii.2022.04.011_bib17","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/j.1572-0241.2003.07332.x","article-title":"Health-state utilities and quality of life in hepatitis C patients","volume":"98","author":"Chong","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jmii.2022.04.011_bib18","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1111\/j.1572-0241.2006.00544.x","article-title":"Sexual dysfunction is highly prevalent among men with chronic hepatitis C virus infection and negatively impacts health-related quality of life","volume":"101","author":"Danoff","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jmii.2022.04.011_bib19","article-title":"Itemization difference of patient-reported outcome in patients with chronic liver disease","volume":"17","author":"Lin","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.jmii.2022.04.011_bib20","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jhep.2014.04.003","article-title":"Patient-reported outcomes assessment in chronic hepatitis C treated with sofosbuvir and ribavirin: the VALENCE study","volume":"61","author":"Younossi","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jmii.2022.04.011_bib21","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/apt.13090","article-title":"Systematic review: patient-reported outcomes in chronic hepatitis C--the impact of liver disease and new treatment regimens","volume":"41","author":"Younossi","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jmii.2022.04.011_bib22","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jhep.2016.02.042","article-title":"Sofosbuvir\/velpatasvir improves patient-reported outcomes in HCV patients: results from ASTRAL-1 placebo-controlled trial","volume":"65","author":"Younossi","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.jmii.2022.04.011_bib23","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12876-017-0581-1","article-title":"Health-related quality of Life in patients with chronic hepatitis C receiving Sofosbuvir-based treatment, with and without Interferon: a prospective observational study in Egypt","volume":"17","author":"Youssef","year":"2017","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jmii.2022.04.011_bib24","doi-asserted-by":"crossref","first-page":"6928","DOI":"10.3748\/wjg.v25.i48.6928","article-title":"Hepatitis C virus eradication with directly acting antivirals improves health-related quality of life and psychological symptoms","volume":"25","author":"Nardelli","year":"2019","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jmii.2022.04.011_bib25","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jhep.2019.04.016","article-title":"Patient-reported symptoms during and after direct-acting antiviral therapies for chronic hepatitis C: the PROP UP study","volume":"71","author":"Evon","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.jmii.2022.04.011_bib26","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.jfma.2020.04.002","article-title":"2020 Taiwan consensus statement on the management of hepatitis C: Part (II) special populations","volume":"119","author":"Yu","year":"2020","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jmii.2022.04.011_bib27","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.jfma.2020.04.003","article-title":"2020 Taiwan consensus statement on the management of hepatitis C: part (I) general population","volume":"119","author":"Yu","year":"2020","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jmii.2022.04.011_bib28","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","article-title":"The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research","volume":"28","author":"Buysse","year":"1989","journal-title":"Psychiatr Res"},{"key":"10.1016\/j.jmii.2022.04.011_bib29","first-page":"688","article-title":"Development of the Taiwanese depression questionnaire","volume":"23","author":"Lee","year":"2000","journal-title":"Chang Gung Med J"},{"issue":"Suppl 11","key":"10.1016\/j.jmii.2022.04.011_bib30","first-page":"S467","article-title":"Measures of anxiety: state-trait anxiety inventory (STAI), beck anxiety inventory (bai), and hospital anxiety and depression scale-anxiety (HADS-A)","volume":"63","author":"Julian","year":"2011","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.jmii.2022.04.011_bib31","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1023\/A:1008841022998","article-title":"Reliability and validity of the Gastrointestinal Symptom Rating Scale in patients with gastroesophageal reflux disease","volume":"7","author":"Revicki","year":"1998","journal-title":"Qual Life Res"},{"key":"10.1016\/j.jmii.2022.04.011_bib32","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1056\/NEJM198110223051704","article-title":"Speech and survival: tradeoffs between quality and quantity of life in laryngeal cancer","volume":"305","author":"McNeil","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmii.2022.04.011_bib33","doi-asserted-by":"crossref","first-page":"445","DOI":"10.17235\/reed.2019.6063\/2018","article-title":"Long-term changes on health-related quality of life in patients with chronic hepatitis C after viral clearance with direct-acting antiviral agents","volume":"111","author":"Goni Esarte","year":"2019","journal-title":"Rev Esp Enferm Dig"},{"key":"10.1016\/j.jmii.2022.04.011_bib34","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.2147\/PPA.S172732","article-title":"Patient-reported outcomes in individuals with hepatitis C virus infection treated with elbasvir\/grazoprevir","volume":"12","author":"Ng","year":"2018","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.jmii.2022.04.011_bib35","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1590\/s1678-9946201860072","article-title":"Quality of life of Brazilian chronic hepatitis C patients treated with interferon-free therapies","volume":"60","author":"Siqueira","year":"2018","journal-title":"Rev Inst Med Trop Sao Paulo"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118222000652?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118222000652?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:29:34Z","timestamp":1761658174000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118222000652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S1684118222000652"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2022.04.011","relation":{},"ISSN":["1684-1182"],"issn-type":[{"value":"1684-1182","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improvement of patient-reported outcomes in patients achieving sustained virologic response with direct-acting antivirals for hepatitis C virus infection","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2022.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}